JG
RARE icon

Jefferies Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Jefferies Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,133
Closed -$1.38M – 1931
2021
Q1 		$1.38M Buy
+12,133
New +$1.65M 0.01% 795
2020
Q3 		– Sell
-30,910
Closed -$2.42K – 1511
2020
Q2 		$2.42K Buy
30,910
+30,021
+3,377% +$1.99M 0.03% 489
2020
Q1 		$39K Sell
889
-11,679
-93% -$606K ﹤0.01% 1891
2019
Q4 		$537K Buy
+12,568
New +$519K ﹤0.01% 1762
2015
Q4 		– Sell
-11,030
Closed -$1.06M – 2510
2015
Q3 		$1.06M Buy
+11,030
New +$1.26M 0.01% 1175

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return